Systematic Review

Published on 13 May 2024

Effect of ezetimibe–statin combination therapy vs. statin monotherapy on coronary atheroma phenotype and lumen stenosis in patients with coronary artery disease: a meta-analysis and trial sequential analysis

in Drugs Outcomes Research and Policies

Yun-Jing Zhang
Min Xu
Ji-Qiang Duan
De-Jin Wang
Shi-Liang Han

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1343582

Original Research

Accepted on 10 May 2024

Pharmaceutical interventions for drug-related problems in the neonatal intensive care unit: Incidence, types, and acceptability

in Drugs Outcomes Research and Policies

Norhan Attia Ahmed
Ehab Ahmed Fouad
Osama Mahmoud Elasheer
Ahmed Shawky Mohamed

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1391657

Original Research

Published on 10 May 2024

Are Turkish pharmaceutical pricing strategies an access barrier to oncology medicines for Türkiye?

in Drugs Outcomes Research and Policies

Elif Hilal Vural
Tolga Kaskati
İsmail Mert Vural
Mustafa Asım Özalp
Bülent Gümüşel

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1364341

226 views

Original Research

Published on 09 May 2024

Variables affecting new drug prices in South Korea’s pricing system

in Drugs Outcomes Research and Policies

Dong Yun Lee
Seong Ha Cho
Da Hye Lee
Su Jeong Kang
Jong Hyuk Lee

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1370915

691 views

Review

Accepted on 06 May 2024

Osteogenic mechanism of chlorogenic acid and its application in clinical practice

in Drugs Outcomes Research and Policies

Jiayu Shen
Shichen Zhang
Jiayu Zhang
Xin Wei
Zilin Wang
Bing Han

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1396354

Review

Published on 06 May 2024

Shortage of plasma-derived medicinal products: what is next? narrative literature review on its causes and counteracting policies in Italy

in Drugs Outcomes Research and Policies

Matteo Bolcato
Claudio Jommi

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1375891

204 views

Brief Research Report

Published on 02 May 2024

A real-world experience of venetoclax combined with hypomethylating agents vs. monotherapy hypomethylating agents in patients with myelodysplastic syndromes and chronic myelomonocytic leukemia patients

in Drugs Outcomes Research and Policies

Ludan Zhang
Rui Ge
Deng Pan
Pengjie Yue
Jingwen Zhang
Renjie Bian
Xiaojing Yan

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1265840

162 views

Original Research

Accepted on 01 May 2024

Time trends and regional variations in prices of anticancer medicines in China

in Drugs Outcomes Research and Policies

Jinwei Zhang
Shuchen Hu
Xingyu Liu
Xiaoyong Liu
Jieqiong Zhang
Caijun Yang
Yu Fang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1397784

Systematic Review

Published on 01 May 2024

The effect of bupivacaine on analgesia and safety in patients undergoing hemorrhoidectomy: a meta-analysis

in Drugs Outcomes Research and Policies

Haixia Lu
Min Cai
Dongxi Zhou
Weiwei Li
Hanzhong Cao

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1331965

243 views

Original Research

Accepted on 30 Apr 2024

Cost-Effectiveness Analysis of Tislelizumab Plus Chemotherapy as First-Line Treatment for Chinese Advanced or Metastatic Esophageal Squamous Cell Carcinoma

in Drugs Outcomes Research and Policies

Yanhong Liu
Rong Shao

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1225076

Review

Accepted on 30 Apr 2024

Analysis of the orphan drug policy in China

in Drugs Outcomes Research and Policies

Meilin Liu
Yanqin Lu
Junfeng Li
Yongtao Zhang
Shanshan Zhang
Yisheng Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1278710

Opinion

Accepted on 29 Apr 2024

Overlooking the obvious: the importance of communicating safety and risks of opioids- the Israeli context

in Drugs Outcomes Research and Policies

Maram Khazen
Shelly Kamin-Friedman

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1356968

Editorial

Published on 26 Apr 2024

Editorial: Clinical pharmacist service promotes the improvement of medical quality

in Drugs Outcomes Research and Policies

Hao Li
Wei Luan
Zhi-Chun Gu
Shusen Sun
Jianrong Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1418181

188 views

Review

Published on 24 Apr 2024

The application of multi-criteria decision analysis in evaluating the value of drug-oriented intervention: a literature review

in Drugs Outcomes Research and Policies

Pengli Su
Kai Zhi
Huanhuan Xu
Jing Xiao
Jun Liu
Zhong Wang
Qiong Liu
Yanan Yu
Haixia Dang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1245825

215 views

Mini Review

Accepted on 19 Apr 2024

Improvements in technology and the expanding role of Time-Driven Activity-Based costing to increase value in health care provider organizations: a literature review

in Drugs Outcomes Research and Policies

Ana Paula Beck Da Silva Etges, Ph.D, Eng.
Porter Jones
Harry Liu
Xiaoran Zhang
Derek Haas

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1345842

Editorial

Published on 18 Apr 2024

Editorial: Novel methods and technologies for the evaluation of drug outcomes and policies

in Drugs Outcomes Research and Policies

Blythe Adamson
Amr Makady
Grammati Sarri
Omneya Mohamed
Zaheer Babar
Dalia M. Dawoud

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1396034

372 views

Navigation group

Articles

Effect of ezetimibe–statin combination therapy vs. statin monotherapy on coronary atheroma phenotype and lumen stenosis in patients with coronary artery disease: a meta-analysis and trial sequential analysis

Pharmaceutical interventions for drug-related problems in the neonatal intensive care unit: Incidence, types, and acceptability

Are Turkish pharmaceutical pricing strategies an access barrier to oncology medicines for Türkiye?

Variables affecting new drug prices in South Korea’s pricing system

Osteogenic mechanism of chlorogenic acid and its application in clinical practice

Shortage of plasma-derived medicinal products: what is next? narrative literature review on its causes and counteracting policies in Italy

A real-world experience of venetoclax combined with hypomethylating agents vs. monotherapy hypomethylating agents in patients with myelodysplastic syndromes and chronic myelomonocytic leukemia patients

Time trends and regional variations in prices of anticancer medicines in China

The effect of bupivacaine on analgesia and safety in patients undergoing hemorrhoidectomy: a meta-analysis

Cost-Effectiveness Analysis of Tislelizumab Plus Chemotherapy as First-Line Treatment for Chinese Advanced or Metastatic Esophageal Squamous Cell Carcinoma

Analysis of the orphan drug policy in China

Overlooking the obvious: the importance of communicating safety and risks of opioids- the Israeli context

Editorial: Clinical pharmacist service promotes the improvement of medical quality

The application of multi-criteria decision analysis in evaluating the value of drug-oriented intervention: a literature review

Improvements in technology and the expanding role of Time-Driven Activity-Based costing to increase value in health care provider organizations: a literature review

Editorial: Novel methods and technologies for the evaluation of drug outcomes and policies